Tokyo adopts tougher virus rules, starts vaccinating elders
Tokyo adopted tougher measures against the coronavirus Monday as it struggles to curb the rapid spread of a more contagious variant ahead of the Olympics in...
Category: Health
Study shows tanning bed ban would reduce skin cancer rates in minors and cut healthcare costs
A recent study indicates that a U.S. ban on the use of tanning beds among minors would prevent thousands of cases of melanoma in adolescents and...
Brazil now has more young than old COVID patients in ICUs
The number of COVID-19 patients under 40 in intensive care in Brazil surpassed older groups last month, a researcher said Sunday, amid a deadly surge driven...
S. African COVID variant better at bypassing Pfizer/BioNTech jab: Israeli study
The South African coronavirus variant is better at “breaking through” the defences of the Pfizer/BioNTech vaccine than other forms of the virus, Israeli experts said Sunday.
Pubs, hairdressers set to reopen as UK eases virus lockdown
Millions of people in Britain will get their first chance in months for haircuts, casual shopping and restaurant meals on Monday, as the government takes the...
Mutant KRAS and p53 cooperate to drive pancreatic cancer metastasis
Researchers at The University of Texas MD Anderson Cancer Center have discovered that mutant KRAS and p53, the most frequently mutated genes in pancreatic cancer, interact...
Immune-stimulating drug before surgery shows promise in early-stage pancreatic cancer
Giving early-stage pancreatic cancer patients a CD40 immune-stimulating drug helped jumpstart a T cell attack to the notoriously stubborn tumor microenvironment before surgery and other treatments,...
Level of chromosomal abnormality in lung cancer may predict immunotherapy response
Patients with non-small cell lung cancer (NSCLC) whose cancer cells have low levels of aneuploidy—an abnormal number of chromosomes—tend to respond better to immune checkpoint inhibitor...
Personalized cancer vaccine is safe, shows potential benefit against cancer
A personalized cancer vaccine developed with the help of a Mount Sinai computational platform raised no safety concerns and showed potential benefit in patients with different...
New CAR T approach minimizes resistance, helps avoid relapse in non-Hodgkin’s B-cell lymphoma
Early results from a new, pioneering chimeric antigen receptor (CAR) T cell immunotherapy trial led by researchers at the UCLA Jonsson Comprehensive Cancer Center found using...
